Cargando…

The Genomic Landscape of Prostate Cancer

By the age of 80, approximately 80% of men will manifest some cancerous cells within their prostate, indicating that prostate cancer constitutes a major health burden. While this disease is clinically insignificant in most men, it can become lethal in others. The most challenging task for clinicians...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spans, Lien, Clinckemalie, Liesbeth, Helsen, Christine, Vanderschueren, Dirk, Boonen, Steven, Lerut, Evelyne, Joniau, Steven, Claessens, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709705/ https://www.ncbi.nlm.nih.gov/pubmed/23708091 http://dx.doi.org/10.3390/ijms140610822

Ejemplares similares

Comparative Genomic and Transcriptomic Analyses of LNCaP and C4-2B Prostate Cancer Cell Lines
por: Spans, Lien, et al.
Publicado: (2014)

The Role of Single Nucleotide Polymorphisms in Predicting Prostate Cancer Risk and Therapeutic Decision Making
por: Van den Broeck, Thomas, et al.
Publicado: (2014)

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
por: Spans, Lien, et al.
Publicado: (2016)

Comparing the rules of engagement of androgen and glucocorticoid receptors
por: Claessens, Frank, et al.
Publicado: (2017)

Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2020)

Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2021)

Testosterone and the Male Skeleton: A Dual Mode of Action
por: Sinnesael, Mieke, et al.
Publicado: (2011)

FRI475 The Impact Of Suppression Of Androgen Signaling On Thyroid Hormone Homeostasis In Prostate Cancer Patients
por: David, Karel, et al.
Publicado: (2023)

A Giant Mucinous Adenocarcinoma Arising within a Villous Adenoma of the Urachus: Case Report and Review of the Literature
por: Joniau, Steven, et al.
Publicado: (2009)

Calcium and Vitamin D Supplementation in Men
por: Gielen, Evelien, et al.
Publicado: (2011)

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
por: Handle, Florian, et al.
Publicado: (2019)

MiR-205 Is Progressively Down-Regulated in Lymph Node Metastasis but Fails as a Prognostic Biomarker in High-Risk Prostate Cancer
por: Kalogirou, Charis, et al.
Publicado: (2013)

Renal Cell Carcinoma with Synchronous Metastasis to the Calcaneus and Metachronous Metastases to the Ovary and Gallbladder
por: Decoene, Jasper, et al.
Publicado: (2011)

Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients
por: Giesen, Alexander, et al.
Publicado: (2023)

The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients
por: Gevaert, Thomas, et al.
Publicado: (2020)

Comparing the expression profiles of steroid hormone receptors and stromal cell markers in prostate cancer at different Gleason scores
por: Gevaert, Thomas, et al.
Publicado: (2018)

DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
por: Litovkin, Kirill, et al.
Publicado: (2015)

Changes in bone and mineral homeostasis after short-term androgen deprivation therapy with or without androgen receptor signalling inhibitor – substudy of a single-centre, double blind, randomised, placebo-controlled phase 2 trial
por: David, Karel, et al.
Publicado: (2023)

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment
por: Devos, Gaëtan, et al.
Publicado: (2020)

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008)

(18)F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study
por: Emonds, Kimy M, et al.
Publicado: (2013)

Obesity and prostate cancer research
por: Van den Broeck, Thomas, et al.
Publicado: (2013)

RF15 | PMON291 Crystal Structures of Androgen DNA Binding Domain Interacting with its Response Elements (C3(1) ARE and MMTV-GRE)
por: Claessens, Frank, et al.
Publicado: (2022)

The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2
por: Helsen, Christine, et al.
Publicado: (2022)

Male Wolffian adnexal tumor: the first report of long-term follow-up after radical surgical treatment
por: Milonas, Daimantas, et al.
Publicado: (2021)

Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
por: Van Baelen, Anthony, et al.
Publicado: (2012)

Endocrine determinants of incident sarcopenia in middle-aged and elderly European men
por: Gielen, Evelien, et al.
Publicado: (2015)

What is the Need for Prostatic Biomarkers in Prostate Cancer Management?
por: Spahn, Martin, et al.
Publicado: (2015)

The genomic landscape of prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2012)

Risk stratification tools in prostate cancer, where do we stand?
por: Clinckaert, Andries, et al.
Publicado: (2021)

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial
por: Tosco, Lorenzo, et al.
Publicado: (2018)

Assessing the relative efficacy of different agents based on the outcomes from meta-analyses
por: Boonen, S, et al.
Publicado: (2008)

Penile metastasis in prostate cancer patients: Two case reports, surgical excision technique, and literature review
por: Landen, Lucas, et al.
Publicado: (2023)

LBD Dimerization of the Androgen Receptor but Not N/C Interaction Is Crucial for Normal Male Development in Mice
por: El Kharraz, Sarah, et al.
Publicado: (2021)

The Prevalence of Lower Limb and Genital Lymphedema after Prostate Cancer Treatment: A Systematic Review
por: Clinckaert, Andries, et al.
Publicado: (2022)

External validation of Memorial Sloan Kettering Cancer Center nomogram and prediction of optimal candidate for lymph node dissection in clinically localized prostate cancer
por: Milonas, Daimantas, et al.
Publicado: (2020)

Decoding the heterogeneous landscape in the development prostate cancer
por: Segura-Moreno, Yenifer Yamile, et al.
Publicado: (2021)

Collecting duct renal cell carcinoma: a single centre series and review of the literature
por: Vanderbruggen, Wies, et al.
Publicado: (2022)

Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy
por: Devos, Gaëtan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rjt1pe3sik7mqbqr5enand64la